Teva Responds To API Unit Selloff Rumors
Company Says TAPI Remains ‘A Strong Business’ But Acknowledges Reports Of Sale
Amid rumors that Teva is mulling a potential sale of its APIs business, TAPI, the Israeli firm has underlined the strength of the unit while acknowledging that it continuously reviews such opportunities.
